IGF2BP2 and colorectal carcinoma: Similarly, circEZH2 prevents the ubiquitin-dependent degradation of IGF2BP2 by interacting with it and increases IGF2BP2 expression by binding to miR-133b, thereby promoting CRC progression by enhancing the stability of CREB1 mRNA [70].